AstraZeneca's recent full-page newspaper advertisements defending the safety of its cholesterol-lowering pill, Crestor, are "false and misleading," in part because serious concerns remain about the
safety of the drug, federal drug regulators said Wednesday.
Read the whole story at The New York Times, December 23, 2004
»